The CureCloud will generate, aggregate and visualize massive amounts of genomic, immune and clinical data from patients with multiple myeloma, which is a highly heterogeneous disease and therefore requires more specialized treatment. The data will be shared with physicians, researchers and patients to enable the development and distribution of those treatments.
The data hub will include de-identified data from the MMRF, external data sources and the foundation’s CoMMpass study, which identified 12 unique myeloma sub-types and produced the largest genomic dataset of any form of cancer. Additionally, in the fall, patients will be invited to upload their own data to the CureCloud patient registry to further expand its research and treatment capabilities.
More articles about health IT:
How Adventist Health White Memorial used an app to improve OR turnaround time by 10%
9 recent vendor contracts, go-lives
Health tech startup uses digital photos to help detect Parkinson’s disease
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
